Kallam Satish Reddy
Chairman, Dr. Reddy’s Laboratories
Kallam Satish Reddy is a business executive and the current Chairman of Dr. Reddy’s Laboratories. He joined Dr. Reddy’s in 1993 as Executive Director and later was promoted to the role of Managing Director in 1997. He is also a trustee of the Naandi Foundation, which works in the areas that empower the society.
As published on Hyderabad Stories, 30 Nov 2020 · not re-verified
- Master's in Chemistry
- Education
- Purdue University
- Alma Mater
- Pharmaceutical company
- Industry
Related News
Hyderabad-based Divi’s Labs second pharma company with Rs 1 lakh crore market capitalization
City-based Divi’s Laboratories on Thursday became the second pharma player in the country, after Sun Pharma, to enter the elite league of companies with a market capitalization of Rs 1 lakh crore or more.
Belgium forging ties with Hyderabad
Belgium is strengthening its ties with Hyderabad, India’s largest life sciences hub, to help supply vaccines and drugs to global markets, particularly to the Europe region.
Stock market update: Nifty Pharma index jumps nearly 3%; Dr Reddy's Lab climbs 4%
Nifty Pharma index was trading with losses at 11:48 AM (IST) on Monday. Shares of Dr.
Dr Reddy's Laboratories launches succinylcholine chloride injection in US
Dr. Reddy’s Laboratories Ltd has launched Succinylcholine Chloride injection, a therapeutic equivalent generic version of Quelicin (Succinylcholine Chloride) injection, in the US market.
Dr Reddy’s, RDIF receive approval to conduct clinical trial for Sputnik V vaccine
Hyderabad-based pharmaceuticals company Dr Reddy’s Laboratories and Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, announced that they have received approval from the Drug Control General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for Sputnik V vaccine in India.
Provenance
Sources
Explore the directory
